Muscle toxicity of drugs: when drugs turn physiology into pathophysiology

L Janssen, NAE Allard, CGJ Saris… - Physiological …, 2020 - journals.physiology.org
Drugs are prescribed to manage or prevent symptoms and diseases, but may sometimes
cause unexpected toxicity to muscles. The symptomatology and clinical manifestations of the …

Statins and muscle pain

JV Pergolizzi Jr, F Coluzzi, RD Colucci… - Expert Review of …, 2020 - Taylor & Francis
Introduction: Statins remain among the most frequently prescribed drugs and constitute a
cornerstone in the prevention of cardiovascular disease. However, muscle symptoms are …

Lipid-lowering therapies for cardiovascular disease prevention and management in primary care: PEER umbrella systematic review of systematic reviews

N Dugré, AJ Lindblad, D Perry, GM Allan… - Canadian Family …, 2023 - cfp.ca
Objective To assess the benefits and harms of lipid-lowering therapies used to prevent or
manage cardiovascular disease including bile acid sequestrants (BAS), ezetimibe, fibrates …

Characteristics of lipid profile and effectiveness of management of dyslipidaemia in patients with acute coronary syndromes–data from the TERCET registry with …

K Dyrbus, M Gasior, P Desperak, J Nowak… - Pharmacological …, 2019 - Elsevier
Despite well-defined therapeutic low-density lipoprotein cholesterol (LDL-C) target in the
highest-risk population, low percentage of patients is administered with intensive lipid …

The effect of probiotic fermented milk products on blood lipid concentrations: A systematic review and meta-analysis of randomized controlled trials

R Ziaei, A Ghavami, S Khalesi, R Ghiasvand… - Nutrition, Metabolism …, 2021 - Elsevier
Aim Fermented milk products are suggested as a supplementary therapy to help reduce
blood lipid levels. However, the results of clinical studies are conflicting. Data synthesis This …

Comparative muscle tolerability of different types and intensities of statins: a network meta-analysis of double-blind randomized controlled trials

Q Hou, Y Chen, Y Zhang, C Pang - Cardiovascular Drugs and Therapy, 2024 - Springer
Purpose The benefits of statins for ischemic cardio-cerebrovascular diseases are well
known. However, concerns around muscle adverse events still exist. We therefore aimed to …

Statin intolerance: an updated, narrative review mainly focusing on muscle adverse effects

JJ Li, HH Liu, NQ Wu, KK Yeo, K Tan… - Expert opinion on …, 2020 - Taylor & Francis
Introduction Statins have been established as the standard of care for dyslipidemia and
preventing cardiovascular diseases while posing few safety concerns. However …

Association between dietary patterns and sociodemographics: A cross‐sectional study of Australian nursing students

SL Williams, C Vandelanotte, C Irwin… - Nursing & health …, 2020 - Wiley Online Library
Lack of time, financial issues, and stressful clinical and educational environments in nursing
studies promote higher intakes of convenience and fast foods loaded with fat and sugar …

Persistent safety and efficacy of evolocumab in patients with statin intolerance: a subset analysis of the OSLER open-label extension studies

L Cho, R Dent, ESG Stroes, EA Stein, D Sullivan… - … Drugs and Therapy, 2018 - Springer
Purpose Evolocumab reduced low-density lipoprotein cholesterol (LDL-C) in 12-week trials
in statin-intolerant patients (GAUSS-1 and GAUSS-2); however, the persistence of efficacy …

Efficacy and safety profiles of oral atorvastatin-loaded nanoparticles: effect of size modulation on biodistribution

IS Ahmed, R El Hosary, MA Hassan… - Molecular …, 2018 - ACS Publications
Atorvastatin calcium (AC)-loaded nanoparticles (NPs) of mean particle diameter< 100 nm
and narrow distribution were prepared and characterized. Their in vivo PK as well as PD …